Priority Date: 07.08.12 (EP 20120179587)

TREATMENT OF DRUG RESISTANCE IN HORMONE-SENSITIVE CANCER

  • Application ID: EP13747385
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

operating since 1912
Headquarter in London and 3 offices
active in Legal Services and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 174 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 07.08.2012 - Priority Date (EP 20120179587)
  • 13.02.2014 - Publication A1 (WO2014023791)
  • 17.06.2015 - Publication A1 (EP2882855)